The offer might total up to USD 750m.
发布者：BY CHRISTOPHER DUE KARLSSON，转转请注明出处：https://robotalks.cn/gilead-sciences-and-kymera-therapeutics-sign-deal-on-potential-cancer-drug/
Gilead Sciences and Kymera Therapeutics sign deal on potential cancer drug
赞 (0)
关于作者
Gubra shareholders only a formality away from lucrative payout
上一篇
27 6 月, 2025 9:18 上午
Tough crushing made easier, Sandvik claims, with latest range
下一篇
27 6 月, 2025 9:59 上午
相关推荐
-
Anchorage rewrites wildfire protection plan for the first time since 2007
Despite a transforming environment, an upgraded preparation device will certainly serve as Anchorage’s overview to getting ready for and coping with a raised wildfire threat.
-
When safety and productivity go hand in hand
October is Safe Job Month, an ideal time to assess exactly how automation can make your manufacturing facility more secure and a lot more efficient. Palletizing may be the last act…
-
MassRobotics welcomed MA Secretary of Education, Dr. Patrick Tutwiler
On Monday, July 24th, 2023, MassRobotics invited MA Assistant of Education And Learning, Dr. Patrick Tutwiler, and participants of his group for a scenic tour of our area and to si…
-
MontyPay Takes Home the "Payment Innovation of the Year" Award For Revolutionizing Global Commerce
LONDON–(BUSINESS WIRE)–MontyPay Takes Home the “Payment Innovation of the Year” Award For Revolutionizing Global Commerce
-
New Video Gen AI Lenses for Snapchat Platinum
We’re presenting the initial of our brand-new sophisticated AI video clip Lenses readily available currently solely for Snapchat Platinum, our costs membership rate. These Le…
